Jihane Pakradouni

PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer

Mathilde Guérin, Keyvan Rezaï, Nicolás Isambert et al. · European Journal of Cancer · 2017 · 60 citations

Medicine, Oncology, Pharmacology +14

High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome

Anne-Sophie Chrétien, Raynier Devillier, Samuel Granjeaud et al. · Proceedings of the National Academy of Sciences · 2021 · 60 citations · Full text

Life Sciences, Hematology, Immunology +16

Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial

François Bertucci, Anthony Gonçalvès, Arnaud Guillé et al. · Genome Medicine · 2021 · 57 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Plasma NOV/CCN3 Levels Are Closely Associated with Obesity in Patients with Metabolic Disorders

Jihane Pakradouni, Wilfried Le Goff, Claire Calmel et al. · PLoS ONE · 2013 · 55 citations · Full text

Veterinary Medicine, Endocrinology, Physiology +11

CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer

Stéphane Fattori, Aude Le Roy, Jemila Houacine et al. · Cancer Research · 2023 · 30 citations · Full text

Medicine, Immunology, Oncology +17